Skip to content

High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysis.

Meta-analysis · Am J Hematol · 2011. Source record refreshed; an explanation has not been reviewed.

Meta-analysisSource: PubMed · PMID 21761431

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysis.

Gafter-Gvili A, Leader A, Gurion R et al.
Am J Hematol · 2011

PubMed ID
21761431
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.